EP Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
EP Wealth Advisors's XBI Position: Q3 2026 in Review
EP Wealth Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 38% in Q3 2026, buying an estimated $359K and bringing the position to 8,206 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #626.
EP Wealth Advisors first reported a position in XBI in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.78M in Q2 2023. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- EP Wealth Advisors held 8,206 shares of State Street SPDR S&P Biotech ETF worth $1.29M as of Q3 2026.
- EP Wealth Advisors bought 2,273 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $359K.
- State Street SPDR S&P Biotech ETF made up 0.01% of EP Wealth Advisors's portfolio in Q3 2026, its #626 holding.
- EP Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 18 quarters since.
- EP Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.78M in Q2 2023.
- 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on EP Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.